Glenmark Pharmaceuticals declines 13% in two days on profit booking

The stock has jumped 40 per cent in the intra-day trade on Monday after the firm received approval for Favipiravir's (Fabiflu), a potential Covid-19 drug, by the Drug Controller General of India

from Home Page https://ift.tt/3fKuNw6